Jane Street’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-427
Closed -$3.9K 10470
2024
Q1
$3.9K Buy
+427
New +$2.69K ﹤0.01% 9031
2022
Q2
Sell
-569
Closed -$72K 11224
2022
Q1
$72K Buy
+569
New +$58.7K ﹤0.01% 9577
2018
Q2
Sell
-21
Closed -$38K 5767
2018
Q1
$38K Buy
+21
New +$35.6K ﹤0.01% 4685
2013
Q3
Hold
0
-$16K 3214
2013
Q2
Hold
0
2600

Jane Street's YTEN Position: Q2 2024 in Review

Jane Street sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 427 shares — an estimated $3.9K sold.

Jane Street first reported a position in YTEN in Q1 2018 and held it in 3 quarters. The position peaked at $72K in Q1 2022. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.

  • Jane Street reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jane Street sold 427 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $3.9K.
  • Jane Street first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
  • Jane Street's Yield10 Bioscience, Inc. Common Stock position peaked at $72K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.